The 20 Best Severe Acute Respiratory Syndrome (SARS) Doctors Near Me in Baltimore, MD

Daniel Brodie is an Intensive Care Medicine specialist and a Pulmonary Medicine provider practicing medicine in Baltimore, Maryland. Dr. Brodie is rated as a Distinguished provider by MediFind in the treatment of Severe Acute Respiratory Syndrome (SARS). He is also highly rated in 8 other conditions, according to our data. His clinical expertise encompasses Acute Respiratory Distress Syndrome (ARDS), COVID-19, Respiratory Acidosis, Embolectomy, and Lung Transplant. Dr. Brodie is board certified in American Board Of Internal Medicine.

Dr. Yukari Manabe is a Professor in the Division of Infectious Diseases in the Department of Medicine with secondary appointments in the Bloomberg School of Public Health Department of International Health and the Department of Microbiology and Molecular Immunology. Dr. Manabe began her career working on the basic science aspects of tuberculosis (TB) immunopathogenesis in comparative animal models of infection, particularly latency, reactivation, and immune reconstitution inflammatory syndrome (IRIS) in the rabbit model within the Johns Hopkins Center for Tuberculosis Research. In 2007, she was seconded to the Infectious Diseases Institute (IDI) at Makerere College of Health Sciences as the Associate Medical Laboratory Director of the College of American Pathologists certified Makerere University-Johns Hopkins University Clinical Core Lab to study antiretroviral associated TB and IRIS. She then became the Head of Research at the IDI in 2008 until 2012 where she built research capacity and infrastructure to train Ugandan investigators. Since returning to Hopkins, she has become the PI of the Johns Hopkins POC STD Center (U54 funded through NIH) which is part of the newly formed Johns Hopkins Center for Innovative Diagnostics for Infectious Diseases. The Center develops new diagnostics, funds development for point-of-care diagnostics, evaluates (validation and verification) new technology, and performs pre-clinical studies to accelerate the development of infectious disease assays (STIs, TB, acute febrile illness, HIV, syphilis, viral hepatitis). Dr. Manabe is particularly interested in rapid, point-of-care infectious disease diagnostics suitable for the resource-limited settings particularly in sub-Saharan Africa (SSA). Her research has focused on accuracy testing of various rapid, point-of-care diagnostics for HIV and related infectious diseases of clinical importance in SSA. Studies have ranged from evaluations of performance accuracy through clinical implementation science studies on the patient-centered outcomes and impactful use of new rapid diagnostics. Dr. Manabe obtained her undergraduate degree from Yale University and her M.D. from Columbia University College of Physicians and Surgeons. After completing both her residency in Internal Medicine and fellowship in Infectious Diseases at Johns Hopkins Hospital, she joined the faculty in 1999. Dr. Manabe is rated as a Distinguished provider by MediFind in the treatment of Severe Acute Respiratory Syndrome (SARS). She is also highly rated in 17 other conditions, according to our data. Her clinical expertise encompasses HIV/AIDS, Gonorrhea, Cryptococcosis, Meningitis, and Tissue Biopsy.

Dr. Hager is a specialist in Critical Care Medicine. He is an expert in the diagnosis and management of all forms of acute respiratory failure, including asthma, pneumonia, C.O.P.D., neuromuscular diseases, and the acute respiratory distress syndrome. He also has extensive experience in the management of other life-threatening conditions such as pulmonary embolism, gastrointestinal hemorrhage, shock from sepsis, hypovolemia, and heart disease, and metabolic emergencies such as diabetic ketoacidosis and hyperosmolar states. Dr. Hager is rated as a Distinguished provider by MediFind in the treatment of Severe Acute Respiratory Syndrome (SARS). He is also highly rated in 5 other conditions, according to our data. His clinical expertise encompasses Severe Acute Respiratory Syndrome (SARS), COVID-19, Cerebral Hypoxia, and Acute Respiratory Distress Syndrome (ARDS). Dr. Hager is board certified in American Board Of Internal Medicine.

Dr. Werbel is a physician-scientist who provides consultative care for patients at Johns Hopkins who experience infectious disease complications before and after organ transplant, as well as in the setting of solid tumors or blood cancers. His research with the Johns Hopkins Transplant Research Center uses a combination of epidemiological and laboratory methods to better personalize the prevention of infectious complications among patients with complex immunodeficiencies. This includes using national cohort studies and clinical trials to optimize the use of vaccines and other prophylactic therapies for high-risk immunosuppressed populations. Dr. Werbel is rated as a Distinguished provider by MediFind in the treatment of Severe Acute Respiratory Syndrome (SARS). He is also highly rated in 3 other conditions, according to our data. His clinical expertise encompasses COVID-19, Severe Acute Respiratory Syndrome (SARS), HIV/AIDS, and Hepatitis. Dr. Werbel is board certified in American Board Of Internal Medicine.

Dr. Annie Antar is an assistant professor of medicine at the Johns Hopkins University School of Medicine. Her areas of clinical expertise include internal medicine and infectious diseases. Her areas of research expertise include long COVID, long COVID in people living with HIV, HIV cure, and suboptimal CD4 response after antiretroviral therapy. Dr. Antar earned her undergraduate degree from Harvard University and her M.D. and Ph.D. degrees from Vanderbilt University School of Medicine. She completed both her residency in internal medicine and fellowship in infectious diseases at the Johns Hopkins Hospital. Dr. Antar is rated as an Advanced provider by MediFind in the treatment of Severe Acute Respiratory Syndrome (SARS). She is also highly rated in 3 other conditions, according to our data. Her clinical expertise encompasses Long Haul COVID, Severe Acute Respiratory Syndrome (SARS), COVID-19, and HIV/AIDS. Dr. Antar is board certified in American Board Of Internal Medicine.

Olivia Kates is an Infectious Disease provider practicing medicine in Baltimore, Maryland. Dr. Kates is rated as an Advanced provider by MediFind in the treatment of Severe Acute Respiratory Syndrome (SARS). She is also highly rated in 3 other conditions, according to our data. Her clinical expertise encompasses COVID-19, Diphtheria, Severe Acute Respiratory Syndrome (SARS), and Listeriosis. Dr. Kates is board certified in American Board Of Internal Medicine.

Kathleen Neuzil is an Infectious Disease provider practicing medicine in Baltimore, Maryland. Dr. Neuzil is rated as a Distinguished provider by MediFind in the treatment of Severe Acute Respiratory Syndrome (SARS). She is also highly rated in 9 other conditions, according to our data. Her clinical expertise encompasses Typhoid Fever, Salmonella Enterocolitis, Flu, and COVID-19.

Dr. Kelly Gebo is a graduate of The Johns Hopkins University School of Medicine. She also earned an MPH in Epidemiology from The Johns Hopkins Bloomberg School of Public Health. She completed residency training in Internal Medicine at The Johns Hopkins Hospital followed by an infectious diseases fellowship and two additional years of fellowship training as a Robert Wood Johnson Clinical Scholar, also at Hopkins. Her clinical and research interests include clinical outcomes and healthcare utilization research within infectious diseases. She was Director of the JHU Public Health Studies Program between the Krieger School for Arts and Sciences and the Bloomberg School for Public Health, was an American Council of Education Fellow (hosted at the University of Pennsylvania) and was the inaugural Vice Provost for Education at Johns Hopkins. She was on sabbatical at Stanford University School of Medicine 2019-20 and served as the Chief Medical and Scientific Officer for the All of Us Research Program 2018-2020. She currently serves as the director of the Johns Hopkins Clinical Research Scholars Program and is Deputy Director of the Johns Hopkins Institute for Clinical and Translational Research. She has mentored undergraduate, public health and medical students, trainees, and junior faculty on infectious diseases and health services projects. She has authored or co-authored numerous chapters and over 250 papers. She is a member of the American Society of Clinical Investigation and has been awarded the David Levine Prize for mentoring at Johns Hopkins. LinkedIn https://www.linkedin.com/in/kelly-gebo-13377811/. Dr. Gebo is rated as an Advanced provider by MediFind in the treatment of Severe Acute Respiratory Syndrome (SARS). She is also highly rated in 12 other conditions, according to our data. Her clinical expertise encompasses HIV/AIDS, Myelitis, AIDS Dysmorphic Syndrome, and AIDS Dementia Complex. Dr. Gebo is board certified in American Board Of Internal Medicine.

Dr. Joel Blankson is an associate professor of medicine at the Johns Hopkins University School of Medicine. He also holds an appointment in molecular and comparative pathobiology. His areas of clinical expertise include HIV pathogenesis and infectious disease. Dr. Blankson earned his M.D. from Cornell University Medical College and his Ph.D. from Rockefeller University. He completed his residency and a fellowship in infectious disease at Johns Hopkins. His research interests include the natural control of HIV-1 infection. Dr. Blankson is rated as an Advanced provider by MediFind in the treatment of Severe Acute Respiratory Syndrome (SARS). He is also highly rated in 9 other conditions, according to our data. His clinical expertise encompasses HIV/AIDS, Myelitis, AIDS Dementia Complex, and AIDS Dysmorphic Syndrome. Dr. Blankson is board certified in American Board Of Internal Medicine.

A leading expert on brain injury, Dr. Daniel F. Hanley has been a professor of neurology, neurosurgery, and anesthesiology/critical care medicine at the Johns Hopkins University School of Medicine since 1996 and was named the Jeffrey and Harriet Legum Chair of Acute Care Neurology. Dr. Hanley founded and directed the Johns Hopkins Neurocritical Care Unit, one of the first critical care units dedicated solely to neurosurgical and neurological patients. Subsequently, in 1999, he founded and continues to direct the BIOS Clinical Trials Coordinating Center (BIOS CTCC), formerly known as the Division of Brain Injury Outcomes. Under Dr. Hanley’s leadership, BIOS CTCC, an academic contract research organization based at Johns Hopkins, has organized and completed more than 20 large clinical trials. He has been awarded over 70 clinical and basic research grants, predominantly from the National Institutes of Health and the FDA Orphan Products Grants Program. Dr. Hanley’s 40-year career in medicine has focused on clinical trial design, the organization and interpretation of drug and device trials, the development of strategic research plans, and FDA regulatory compliance. He has led international, NIH-sponsored trials including the MISTIE III and CLEAR III trials investigating minimally invasive neurosurgical techniques to treat hemorrhagic stroke. As principal investigator for the National Center for Advancing Translational Sciences (NCATS) Johns Hopkins Trial Innovation Center, Dr. Hanley leads collaborative efforts to advance education and therapeutics through innovative CTSA clinical trials. Currently, Dr. Hanley is the PI or multi-PI for several ongoing trials. These include a multisite phase 2/3 randomized controlled dementia prevention trial (MAP), a large multicenter clinical trial involving automated monitoring of atrial fibrillation (REACT AF), and a first-in-patient phase 2a biomarker and edema attenuation in intracerebral hemorrhage trial (BEACH). Dr. Hanley has published over 400 peer-reviewed articles and book chapters, received the Humboldt Research Prize for accomplishments in brain injury research, and mentored nearly 100 researchers. His trainees, which include a large number of trialists, have led 25 brain intensive care units, and over 40 have been named full professors, program leaders, or department chairs. He has served on public boards including the American Academy of Neurology, National Stroke Association, and NIH National Institute of Nursing Research. Dr. Hanley is rated as an Advanced provider by MediFind in the treatment of Severe Acute Respiratory Syndrome (SARS). He is also highly rated in 5 other conditions, according to our data. His clinical expertise encompasses Stroke, Hydrocephalus, Vertigo, Thrombectomy, and Gastrostomy. Dr. Hanley is board certified in American Board Of Psychiatry And Neurology and American Board Of Internal Medicine.

Dr. Gregory Kirk is a professor of medicine at the Johns Hopkins University School of Medicine. He holds joint appointments in oncology and, at the Johns Hopkins Bloomberg School of Public Health, in epidemiology. His areas of clinical expertise include epidemiology, hepatitis, HIV, AIDS and infectious diseases. He serves as the vice chair for clinical and translational research at the Johns Hopkins School of Medicine. Dr. Kirk received his undergraduate degree from Oklahoma State University. He earned a Ph.D. and M.P.H. from the Johns Hopkins Bloomberg School of Public Health. He earned his M.D. from the University of Oklahoma Health Sciences Center College of Medicine. He completed a residency in preventative medicine at the Johns Hopkins Bloomberg School of Public Health and in internal medicine at Georgetown University. He performed a fellowship in infectious diseases at the National Institute of Allergy and Infectious Diseases. His research focuses on understanding and preventing the long-term consequences of chronic HIV infection, particularly the malignant complications of HIV and viral hepatitis. He has extensive research and clinical experience in Africa, leading the Gambia Liver Cancer Study, one of the largest studies of hepatocellular carcinoma (HCC) performed in the continent, in addition to years of collaborative research in Uganda. Dr. Kirk pioneered the use of elastography and application of novel aflatoxin-associated biomarkers of HCC risk to be applied in Consortium projects. He has strong, multidisciplinary team leadership skills as principal investigator of the ALIVE cohort and several other collaborative studies in Baltimore. Dr. Kirk is rated as an Advanced provider by MediFind in the treatment of Severe Acute Respiratory Syndrome (SARS). He is also highly rated in 6 other conditions, according to our data. His clinical expertise encompasses HIV/AIDS, Hepatitis C, Hepatitis, and COVID-19. Dr. Kirk is board certified in American Board Of Internal Medicine.

Dr. Thomas Quinn is professor of medicine and pathology in the Johns Hopkins School of Medicine and professor of international health, epidemiology, and molecular microbiology and immunology in The Johns Hopkins School of Public Health, and professor of nursing in the Johns Hopkins School of Nursing. In 2006 he was appointed founding Director of the Johns Hopkins University Center for Global Health. He serves as advisor/consultant on HIV and STDs to the World Health Organization, Office of the Global AIDS Coordinator (PEPFAR), UNAIDS, and the FDA. He serves as Associate Director for International Research at the National Institute of Allergy and Infectious Diseases. He is a member of the Institute of Medicine of the National Academy of Sciences, and is a fellow of the American Association for the Advancement of Science. He is a fellow of the Infectious Diseases Society of America and a member of the American Association of Physicians. He is an author of over 900 publications on HIV, STDs, and infectious diseases, and serves on multiple editorial boards. Among his professional activities, Dr. Quinn is an alternate member of the Technical Panel of the Global Fund to Fight AIDS, Malaria, and Tuberculosis and has been on Advisor/Consultant on HIV and STDs to the World Health Organization, UNAIDS, and the U.S. Food and Drug Administration. In October 2004 he received membership in the Institute of Medicine. Dr. Quinn is rated as an Advanced provider by MediFind in the treatment of Severe Acute Respiratory Syndrome (SARS). He is also highly rated in 12 other conditions, according to our data. His clinical expertise encompasses HIV/AIDS, Genital Herpes, Chlamydia, and Human Papillomavirus Infection. Dr. Quinn is board certified in American Board Of Internal Medicine.

Dr. Galiatsatos is a pulmonary and critical care medicine physician. He is an expert in the diagnosis and treatment of obstructive lung disease, tobacco cessation, and in the care of critically ill patients in the Medical ICU. He is a member of the Obstructive Lung Disease Group at Johns Hopkins, oversees the Tobacco Treatment Clinic and provides teaching to medical students and residents at Johns Hopkins. Dr. Galiatsatos is rated as an Advanced provider by MediFind in the treatment of Severe Acute Respiratory Syndrome (SARS). He is also highly rated in 4 other conditions, according to our data. His clinical expertise encompasses Pulmonary Arteriovenous Fistula, Chronic Obstructive Pulmonary Disease (COPD), COVID-19, and Severe Acute Respiratory Syndrome (SARS). Dr. Galiatsatos is board certified in American Board Of Internal Medicine.

John Baddley is an Infectious Disease provider practicing medicine in Baltimore, Maryland. Dr. Baddley is rated as an Experienced provider by MediFind in the treatment of Severe Acute Respiratory Syndrome (SARS). He is also highly rated in 14 other conditions, according to our data. His clinical expertise encompasses Cryptococcosis, Shingles, Sepsis, and Febrile Neutropenia. Dr. Baddley is board certified in American Board Of Internal Medicine.

"Albert W. Wu is Professor of Health Policy and Management and Medicine, with joint appointments in Epidemiology, International Health, Medicine and Surgery. He received BA and MD degrees from Cornell University, and completed an Internal Medicine residency at the Mount Sinai Hospital and UC San Diego. He was a Robert Wood Johnson Clinical Scholar at UCSF and received an MPH from UC Berkeley. His research and teaching focus on patient outcomes and quality of care. He was the first to measure the quality of life impact of antiretroviral therapy in HIV clinical trials. He developed the MOS-HIV health survey, and other questionnaires to measure quality of life, adherence, satisfaction, attitudes and behaviors for people with chronic disease. He was co-founder and director of the outcomes research committee of the AIDS Clinical Trials Group of the NIH, and President of the International Society for Quality of Life. He advises many US and international organizations on PRO methods. He is director of the Johns Hopkins Center for Health Services and Outcomes Research, He has studied the handling of medical errors since 1988, was a member of the Institute of Medicine committee on identifying and preventing medication errors, and was Senior Adviser for Patient Safety to WHO in Geneva. His current research is on incorporating PROs into the electronic health record, PRO-performance measures for primary care, supporting healthcare workers after adverse events, and creating a network community based organizations. He has authored over 400 peer review publications. and is co-author of the recent book ""New Horizons in Patient Safety, Understanding Communication. He leads the PhD program in health services research, the Masters of Applied Science in Patient Safety & Healthcare Quality, and the Certificate program in Quality, Patient Safety and Outcomes Research in the Johns Hopkins Bloomberg School of Public Health. He maintains a clinical practice in general internal medicine.". Dr. Wu is rated as an Experienced provider by MediFind in the treatment of Severe Acute Respiratory Syndrome (SARS). His clinical expertise encompasses Severe Acute Respiratory Syndrome (SARS), COVID-19, HIV/AIDS, and Sepsis. Dr. Wu is board certified in American Board Of Internal Medicine.

Amita Gupta is an Infectious Disease provider practicing medicine in Baltimore, Maryland. Dr. Gupta is rated as an Experienced provider by MediFind in the treatment of Severe Acute Respiratory Syndrome (SARS). She is also highly rated in 5 other conditions, according to our data. Her clinical expertise encompasses HIV/AIDS, Myelitis, AIDS Dysmorphic Syndrome, and AIDS Dementia Complex. Dr. Gupta is board certified in American Board Of Internal Medicine.

Neurologist Scott Newsome specializes in the care of patients with neuroimmunological and neuroinflammatory disorders of the central nervous system. He works within the Division of Neuroimmunology and Neurological Infections at The Johns Hopkins Hospital, and has special interest in evaluating and treating patients with multiple sclerosis, transverse myelitis, neuromyelitis optica and stiff person syndrome. After completing fellowship training, Dr. Newsome joined the Johns Hopkins Multiple Sclerosis and Transverse Myelitis Centers, and he is the director of the Johns Hopkins Neurosciences Consultation and Infusion Center and the Stiff Person Syndrome Center. He is also director of the Johns Hopkins Neuroimmunology and Neurological Infectious Disease Fellowship Program and co-director of the Multiple Sclerosis Experimental Therapeutics Program. Dr. Newsome received his medical degree from the New York College of Osteopathic Medicine, with honors. During his neurology residency, he was awarded the Golden Apple Outstanding Resident Teaching Award, and later was chosen to be chief resident. He subsequently completed a fellowship in neuroimmunology at The Johns Hopkins Hospital with the support of a Sylvia Lawry Physician Fellowship Award from the National Multiple Sclerosis Society. Identifying and testing novel therapies and therapeutic strategies for multiple sclerosis and other neuroimmunological disorders is Dr. Newsome’s main research focus. Other research endeavors include validating the use of new quantitative clinical outcome measures and imaging techniques in multiple sclerosis and identifying risk factors of disease onset and severity, response to treatment and long-term outcomes in neuroimmunological disorders. An adviser for the National Multiple Sclerosis Society and a member of the Miller-Coulson Academy of Clinical Excellence, Dr. Newsome has also served as president of the Consortium of Multiple Sclerosis Centers. Dr. Newsome is rated as an Experienced provider by MediFind in the treatment of Severe Acute Respiratory Syndrome (SARS). He is also highly rated in 15 other conditions, according to our data. His clinical expertise encompasses Stiff Person Syndrome, Multiple Sclerosis (MS), Transverse Myelitis, and Relapsing Multiple Sclerosis (RMS). Dr. Newsome is board certified in American Board Of Psychiatry And Neurology.

Dr. Allison L. Agwu, MD, ScM, FAAP, FIDSA is Professor of pediatric and adult infectious diseases at the Johns Hopkins University School of Medicine. Her clinical interests include HIV/AIDS and infectious disease. Dr. Agwu earned her medical degree from the University of Maryland School of Medicine. She completed a residency in pediatrics and internal medicine at Case Western Reserve University (University Hospitals of Cleveland/ Rainbow Babies and Children’s Hospital), and a combined fellowship in pediatric and adult infectious diseases at the Johns Hopkins School of Medicine. Dr. Agwu's clinical and research interests focuses on children, adolescents, and young adults who are at-risk or living with HIV and their families. Clinically, she provides inpatient and outpatient pediatric infectious diseases' consultations and leads the Pediatric Adolescent HIV/AIDS Program, which provides multidisciplinary for those living with or affected by HIV. Further, she leads the young adult transition clinic, the Accessing Care Early (ACE) Clinic. Both programs are longstanding Ryan White Federal Grant-funded programs. Her overarching research goal is to decipher, address, and minimize disparities in treatment and outcomes for those living with HIV. Toward this goal, she oversees her own independent, longstanding, federally funded clinical research program and serves as principal investigator of the Johns Hopkins sites of the International Maternal, Pediatric, and Adolescent AIDS Clinical Trials (IMPAACT) Network and the Adolescent Trials' Network (ATN). Her research interests include optimizing outcomes for youth at-risk for and living with HIV, management and treatment strategies, and minimizing disparities in the use of antiretroviral therapy (ART) and outcomes. Other special interests include epidemiologic approaches to HIV, drug resistance, and clinical trials. She is a member of the Infectious Diseases Society of America, the Pediatric Infectious Diseases Society, and the American Academy of Pediatrics. Dr. Agwu is Chair of the HIV Medicine Association. Dr. Agwu is rated as an Experienced provider by MediFind in the treatment of Severe Acute Respiratory Syndrome (SARS). She is also highly rated in 3 other conditions, according to our data. Her clinical expertise encompasses HIV/AIDS, Gonorrhea, Chlamydia, and COVID-19. Dr. Agwu is board certified in American Board Of Pediatrics.

Dr. Pali Dedhiya Shah is a pulmonary and critical care physician. She is an expert in the diagnosis and treatment of advanced lung disease and lung transplantation. She is the medical director of the Johns Hopkins Lung Transplant program. She is a member of the International Society for Heart and Lung transplantation and provides teaching to medical students, residents and fellows at Johns Hopkins. Dr. Shah earned her medical degree from Jefferson Medical College of Thomas Jefferson University. She completed her residency at the Hospital of the University of Pennsylvania and performed a fellowship in pulmonary and critical care medicine at Johns Hopkins. Dr. Shah joined the Johns Hopkins faculty as an assistant professor of medicine in 2011. Dr. Shah is rated as an Experienced provider by MediFind in the treatment of Severe Acute Respiratory Syndrome (SARS). She is also highly rated in 9 other conditions, according to our data. Her clinical expertise encompasses Pulmonary Fibrosis, Lung Metastases, Acute Interstitial Pneumonia, Interstitial Lung Disease, and Lung Transplant.

Dr. Matthew Hamill is interested in all aspects of Sexually Transmitted Infections (STI) and HIV. This includes, prevention, treatment, and retention in care. His research focuses on rapid, Point-of-Care diagnostics for STI in low-income settings. He provides patient-focused treatment for those with, or at risk of, STI and HIV (including Pre Exposure Prophylaxis/PrEP). He has expertise in providing care for LGBTQ+ communities. Dr. Hamill is a UK-trained physician, he received his medical degree in 1998 (MB ChB), trained in internal medicine followed by sexual health/HIV training in London, UK. He spent 3 years conducting research in Soweto, South Africa. In addition to his primary affiliation with Johns Hopkins School of Medicine, he is also affiliated with the Department of Population, Family, and Reproductive Health at the Bloomberg School of Public Health. Dr. Hamill is rated as an Experienced provider by MediFind in the treatment of Severe Acute Respiratory Syndrome (SARS). He is also highly rated in 9 other conditions, according to our data. His clinical expertise encompasses Syphilis, Gonorrhea, Urethritis, and Neurosyphilis.